
|Articles|July 1, 2004
Exogenous insulin use linked to decreased incidence of non-melanoma skin cancer
Indianapolis -A study has found that type 2 diabetes patients who take insulin have a decreased incidence of non-melanoma skin cancer.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials
2
Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT
3
Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001
4
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
5


















